Skip to Navigation Skip to Search Skip to Content
Search All Centers

The Next Generation of Multiple Myeloma Drugs

Myeloma expert Dr. Thomas Martin discusses the various classes of drugs used to treat myeloma and the next generation of drugs targeting specific pathways in myeloma cells. He shares his hope for treating myeloma as a chronic condition through the development of new drugs and encourages patients to participate in clinical trials to further the progress of treatment expansion. 

Featuring

Partners

Multiple Myeloma Opportunities for Research and Education (MMORE) The University of Texas MD Anderson Cancer Center

Sponsors

The University of Texas MD Anderson Cancer Center

You might also like